GlassScriptPhysician profile
Melanie Berman
NPI 1922759422
$9,013.76
in general payments reported to CMS, 2019-2025
37 companies · $809 in 2025
The $809 reported for 2025 was more than what 82% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,978 · 2023: $2,686 · 2024: $3,541 · 2025: $809.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,956 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,956.11 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,226.66 | 2022-2025 | |
| Novo Nordisk INC | $1,098.42 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $781.72 | 2022-2024 | Mounjaro, Trulicity, Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $737.33 | 2022-2025 | Xifaxan, Cycloset |
| Astrazeneca Pharmaceuticals LP | $675.64 | 2022-2025 | Farxiga, Airsupra, Breztri |
| Bayer Healthcare Pharmaceuticals INC. | $673.18 | 2022-2025 | |
| Glaxosmithkline, LLC. | $480.39 | 2022-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Amgen INC. | $469.11 | 2022-2025 | Repatha, Otezla, Otezla |
| Novartis Pharmaceuticals Corporation | $347.68 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $299.26 | 2022-2025 | Jardiance, Synjardy |
| Takeda Pharmaceuticals U.S.A., INC. | $268.30 | 2022-2025 | Trintellix |
| Esperion Therapeutics, INC. | $239.70 | 2022-2025 | Nexletol |
| Astellas Pharma US INC | $184.14 | 2023-2024 | Veozah |
| Axsome Therapeutics, INC. | $169.61 | 2024-2025 | Auvelity |
| Kowa Pharmaceuticals America, INC. | $106.67 | 2022-2025 | Zoryve, Livalo, Seglentis |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch Health US, LLC | $98.85 | 2022-2025 | Wellbutrin |
| Amarin Pharma, INC. | $96.66 | 2022-2023 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $94.83 | 2022-2025 | Caplyta |
| Dexcom, INC. | $85.63 | 2023-2025 | Dexcom G6 Transmitter |
| Otsuka America Pharmaceutical, INC. | $82.06 | 2023-2024 | Rexulti |
| Exact Sciences Corporation | $78.99 | 2023-2024 | Cologuard Collection Kit |
| Almatica Pharma LLC | $77.07 | 2022-2024 | Loreev Xr |
| Idorsia Pharmaceuticals US INC | $76.07 | 2023 | Quviviq |
| Merck Sharp & Dohme LLC | $70.64 | 2022-2023 | Verquvo, Belsomra |
| Janssen Pharmaceuticals, INC | $61.25 | 2023-2024 | Xarelto |
| Tolmar, INC. | $54.18 | 2023-2025 | Jatenzo |
| Medtronic, INC. | $48.59 | 2022 | |
| Paratek Pharmaceuticals, INC. | $48.39 | 2022 | |
| Pfizer INC. | $47.33 | 2023-2024 | |
| Teva Pharmaceuticals USA, INC. | $43.82 | 2023 | Austedo Xr, Austedo |
| Daiichi Sankyo INC. | $40.70 | 2022 | |
| Inspire Medical Systems, INC. | $35.83 | 2024-2025 | Inspire |
| Inari Medical, INC. | $28.79 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Phathom Pharmaceuticals, INC. | $28.43 | 2024 | Voquezna |
| Xeris Pharmaceuticals, INC. | $21.14 | 2024 | Keveyis |
| Neurocrine Biosciences, INC. | $18.64 | 2022 | |
| Collegium Pharmaceutical, INC. | $18.06 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melanie Berman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.